1-4 of 4
Bhupinder Sharma, MD
Close
Sort by
Journal Articles

WB-DWI MRI Scanning Outperforms FDG PET-CT for the Assessment of Myeloma Disease Burden

Charlotte Pawlyn, MB BChir, Martin F Kaiser, MD, Lucy Fowkes, MD, John R Jones, MD, Faith E Davies, MD, Gareth J Morgan, MD PhD, David Collins, BA, MInstP, Bhupinder Sharma, MD, Angela Riddell, MD, Christina Messiou, MD
Journal: Blood
Blood (2015) 126 (23): 1758.
https://doi.org/10.1182/blood.V126.23.1758.1758
Published: 2015
Journal Articles

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Mary Gleeson, FRCPath, Eliza A Hawkes, MD, Clare Peckitt, MSc, Andrew Wotherspoon, FRCPath, Ayoma Attygalle, PhD, Bhupinder Sharma, MD, Yong Du, MD, Mark Ethell, MD, Michael Potter, PhD, Claire Dearden, MD, Alan Horwich, MD, Ian Chau, MD, David Cunningham, FMedSci
Journal: Blood
Blood (2014) 124 (21): 1719.
https://doi.org/10.1182/blood.V124.21.1719.1719
Published: 2014
Journal Articles

Successful Long-Term Outcomes in Patients with Lymphoma Achieving Only Partial Response on [ 18 f]FDG-PET Prior to Allogeneic Transplant

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Anastasia Constantinidou, Caroline Ebdon, Kabir Mohammed, Mark Ethell, MD, Ian Chau, MD, David Cunningham, FMedSci, Michael Potter, PhD, Bhupinder Sharma, MD
Journal: Blood
Blood (2014) 124 (21): 1249.
https://doi.org/10.1182/blood.V124.21.1249.1249
Published: 2014
Journal Articles

Residual Disease on FDG-PET and Multiple Lines of Prior Therapy Predict Poorer Outcomes Following Autologous Hematopoietic Stem Cell Transplantation for Lymphoma

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Anastasia Constantinidou, Caroline Ebdon, Kabir Mohammed, Mark Ethell, MD, Ian Chau, MD, David Cunningham, FMedSci, Michael Potter, PhD, Bhupinder Sharma, MD
Journal: Blood
Blood (2014) 124 (21): 3971.
https://doi.org/10.1182/blood.V124.21.3971.3971
Published: 2014